» Articles » PMID: 36721578

Assessing the Dynamics of COVID-19 Morbidity and Mortality in Response to Mass Vaccination: A Comparative Study Between Saudi Arabia and the United Kingdom

Overview
Journal Cureus
Date 2023 Feb 1
PMID 36721578
Authors
Affiliations
Soon will be listed here.
Abstract

Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, efforts have been in place to tackle the infection. Mass vaccination programs were regarded as the sole solution to end the pandemic. Here, we compare the differential impact of mass vaccination programs in Saudi Arabia (SA) and the United Kingdom (UK) on COVID-19 morbidity and mortality to determine whether vaccines were solely responsible for the changes observed in the disease dynamics. Methodology We retrospectively collected the number of new cases and deaths throughout 2021 in both SA and the UK. Similarly, the number of vaccine doses delivered in both countries was collected and compared. Results Through 2021, the percentage of daily COVID-19 cases was significantly less in SA than in the UK; however, the percentage of deaths was higher in SA. Interestingly, the percentage of daily cases was significantly reduced in SA upon vaccination. The vaccination coverage of both the first and second doses was higher in the UK compared to SA, and, consequently, the percentage of deaths was significantly reduced in the UK compared to SA. Conclusions The UK vaccination program succeeded in curbing the number of daily deaths compared to SA. SA had better control over the percentage of daily cases, primarily due to the restrictive measures and vaccination, such as the imposed social distancing and mandatory face masks.

Citing Articles

Back to Basics: The Diagnostic Value of a Complete Blood Count in the Clinical Management of COVID-19.

Sayed A Diagnostics (Basel). 2024; 14(17).

PMID: 39272717 PMC: 11393994. DOI: 10.3390/diagnostics14171933.


Evaluating COVID-19 vaccine acceptance among parents in Saudi Arabia: a systematic review examining attitudes, hesitancy, and intentions.

Sayed A Front Public Health. 2024; 12:1327944.

PMID: 38584927 PMC: 10995243. DOI: 10.3389/fpubh.2024.1327944.


COVID-19 vaccine hesitancy and attitudes of subjects with disability and their carers in Saudi Arabia: a cross-sectional study.

Sayed A Front Public Health. 2024; 12:1282581.

PMID: 38481833 PMC: 10933131. DOI: 10.3389/fpubh.2024.1282581.


Developing a COVID-19 Mortality Prediction (CoMPred) Indicator for ICU Diabetic Patients Treated with Tocilizumab in Saudi Arabia: A Proof-of-Concept Study.

Sayed A, Al Nozha O Biomedicines. 2023; 11(10).

PMID: 37893025 PMC: 10603829. DOI: 10.3390/biomedicines11102649.


Uneventful Coadministration of Seasonal Influenza and COVID-19 BNT162b2 Vaccines Two Weeks Post-Influenza Vaccination in an Egg-Allergic Subject: A Case Report.

Sayed A Vaccines (Basel). 2023; 11(5).

PMID: 37243054 PMC: 10222373. DOI: 10.3390/vaccines11050950.


References
1.
Allam A, Sayed A . Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report. J Infect Public Health. 2021; 14(8):1123-1125. PMC: 8276583. DOI: 10.1016/j.jiph.2021.07.006. View

2.
Loubet P, Wittkop L, Tartour E, Parfait B, Barrou B, Blay J . A French cohort for assessing COVID-19 vaccine responses in specific populations. Nat Med. 2021; 27(8):1319-1321. DOI: 10.1038/s41591-021-01435-1. View

3.
Sahin U, Muik A, Vogler I, Derhovanessian E, Kranz L, Vormehr M . BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021; 595(7868):572-577. DOI: 10.1038/s41586-021-03653-6. View

4.
Chadeau-Hyam M, Wang H, Eales O, Haw D, Bodinier B, Whitaker M . SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys. Lancet Respir Med. 2022; 10(4):355-366. PMC: 8786320. DOI: 10.1016/S2213-2600(21)00542-7. View

5.
Sayed A . The Progressive Public Measures of Saudi Arabia to Tackle Covid-19 and Limit Its Spread. Int J Environ Res Public Health. 2021; 18(2). PMC: 7831479. DOI: 10.3390/ijerph18020783. View